Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1666653

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1666653

Airway Clearance Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

PUBLISHED:
PAGES: 140 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Airway Clearance Devices Market reached USD 648.6 million in 2024 and is projected to grow at a CAGR of 4.8% during 2025-2034. This growth is driven by several factors, including ongoing technological advancements, the rising prevalence of chronic respiratory diseases, an aging population, and the increasing incidence of hospital-acquired infections, among others.

Airway Clearance Devices Market - IMG1

The market is segmented by device type, with key categories including intrapulmonary percussive ventilation (IPV), high-frequency chest wall oscillation (HFCWO), mechanical cough assist devices, flutter mucus clearance devices, positive expiratory pressure (PEP), and others. Among these, the HFCWO segment led the market in 2024, generating significant revenue. HFCWO devices are gaining popularity due to their non-invasive nature, offering patients a comfortable airway clearance method. These devices are easy to use and deliver consistent therapy without requiring active participation from the patient, making them particularly suitable for elderly and pediatric patients.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$648.6 Million
Forecast Value$990 Million
CAGR4.8%

In terms of age group, the market is divided into adult and pediatric segments. The adult segment held the largest share in 2024 and is expected to continue its dominance throughout the forecast period, reaching a market value of USD 654 million through 2034. Adults, particularly those recovering from thoracic or abdominal surgeries or respiratory infections, often need airway clearance therapy to avoid complications. This demand is further fueled by the growing trend of home-based treatments. Adults increasingly prefer portable, user-friendly airway clearance devices that enable them to manage chronic respiratory conditions from the comfort of their own homes, reducing the need for frequent hospital visits.

North American airway clearance devices market accounted for USD 254.6 million in 2024 and is expected to grow at a CAGR of 3% during 2025-2034. North America has a high incidence of chronic respiratory conditions, which significantly contributes to the demand for advanced airway clearance technologies. The region's well-established healthcare infrastructure and widespread access to innovative medical devices make it an ideal environment for the adoption of airway clearance devices in both clinical and home care settings. This trend is expected to drive continued market growth, improving patient management and outcomes across the region.

Product Code: 5820

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rise in incidence of respiratory conditions
      • 3.2.1.2 Growing patient awareness and product launches
      • 3.2.1.3 Increasing adoption of non-invasive treatment options
      • 3.2.1.4 Surge in government initiatives towards controlling respiratory disorders
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High device cost and stringent regulatory requirements
  • 3.3 Growth potential analysis
  • 3.4 Pricing analysis, 2023
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Reimbursement scenario
  • 3.7 Technological landscape
  • 3.8 Value chain analysis
  • 3.9 Application potential
  • 3.10 Initiatives/policy landscape
  • 3.11 GAP analysis
  • 3.12 Future market trends
  • 3.13 Porter's analysis
  • 3.14 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Vendor matrix analysis
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 – 2032 ($ Mn, Units)

  • 5.1 Key trends
  • 5.2 High frequency chest wall oscillation (HFCWO)
  • 5.3 Flutter mucus clearance device
  • 5.4 Intrapulmonary percussive ventilation (IPV)
  • 5.5 Mechanical cough assist devices
  • 5.6 Positive expiratory pressure (PEP)
  • 5.7 Other device types

Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Chronic obstructive pulmonary disease (COPD)
  • 6.3 Bronchiectasis
  • 6.4 Cystic fibrosis
  • 6.5 Neuromuscular
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Age Group, 2018 – 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Adult
  • 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By End Use, 2018 – 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospital
  • 8.3 Homecare settings
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ABM Respiratory Care
  • 10.2 Baxter International/Hill-Rom Holdings
  • 10.3 Dima Italia
  • 10.4 Dymedso
  • 10.5 Electromed
  • 10.6 ICU Medical
  • 10.7 Koninklijke Philips N.V.
  • 10.8 Mercury Medical
  • 10.9 Monaghan Medical
  • 10.10 Pari Medical
  • 10.11 Pneumo Care Health
  • 10.12 Sentec
  • 10.13 Tactile Medical
  • 10.14 Thayer Medical
  • 10.15 VORTRAN Medical
  • 10.16 VYAIRE MEDICAL
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!